Evidence map›Paper›PMID 32774121›Full record

ReviewBiochemia medica2020

SARS-CoV-2 - a new challenge for laboratory medicine.

Slavica Dodig, Ivana Čepelak, Daniela Čepelak Dodig, Renata Laškaj

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biochemia medica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Observational
  3. Usefulness of laboratory parameters and chest CT in the early diagnosis of COVID-19.Revista do Instituto de Medicina Tropical de Sao Paulo · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Slavica DodigDepartment of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Ivana ČepelakDepartment of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Daniela Čepelak DodigDepartment for Toxicology, Croatian Institute of Public Health Zagreb, Croatia.
Renata LaškajDepartment of Medical Biochemistry, Hematology and Coagulation, University Hospital for Infectious Diseases, Zagreb, Croatia.
University of Zagreb · HRHrvatski zavod za javno zdravstvo · HRUniversity Hospital Centre Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new corona virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2) causes a disease called COVID-19 (coronavirus disease 2019), that develops mostly in subjects with already impaired immune system function, primarily in the elderly and in individuals with some chronic disease or condition. The reasons for this should be sought in the processes of aging and chronic latent inflammation,

Indexed as

BetacoronavirusClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19Health PersonnelHumansInflammation MediatorsPandemicsPneumonia, ViralSARS-CoV-2Specimen HandlingInflammation MediatorsbiomarkersCOVID-19laboratory medicinepatient safetySARS-CoV-2

Identifiers

PMID32774121
PMCPMC7394259
OpenAlexW3046670748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.